PHRM.L Regulatory News (PHRM)

Phorm, Inc.

('Phorm' or the 'Company')

Block Admission Return

Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, is providing an update to its block admission filed on 9 April 2009 (the "Scheme").

For the period from 9 April 2009 to 9 April 2010, Phorm issued 107,711 common shares with a par value of $0.001 each ("Common Shares") issued in due course under the rules of the Company's 2003 Stock Incentive Plan (the "Plan").

Phorm did not issue and has the following balance of not yet issued securities under the Scheme:

As of 9 April 2010, the Company had an issued share capital of 17,293,863 common shares with a par value of $0.001 each, of which 16,416,203 are trading on AIM under the ticker PHRM, the Reg S line and 832,660 are trading on AIM under the ticker PHRX, the Unrestricted Line. A further 45,000 common shares are held in treasury.

About Phorm:

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience. Phorm's partners include leading ISPs, Publishers, Ad Networks and Advertisers.

Phorm is a Delaware, US incorporated company, with offices in Seoul, Moscow, Sao Paulo and London. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 150 employees and direct contractors.

For more information, please visit: www.phorm.com

Enquiries: